Indication
Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder
1 clinical trial
1 product
Product
CST-103Clinical trial
A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover, Study of the Pharmacodynamic Effects of CST-103 Co-administered With CST-107 on the Central Nervous System in Subjects With Neurodegenerative DisordersStatus: Active (not recruiting), Estimated PCD: 2022-07-04